Skip to main content
Clinical Trials/CTRI/2025/09/094194
CTRI/2025/09/094194
Not yet recruiting
Not Applicable

A Comparative Study of Contrast Computed Tomography and Transesophageal Echocardiography for Assessing Left Atrial Appendage Dimensions

nference Labs Private Limited1 site in 1 country120 target enrollmentStarted: September 22, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
nference Labs Private Limited
Enrollment
120
Locations
1
Primary Endpoint
Inter modality agreement mean bias and 95 percent limits of agreement on Bland Altman analysis for LAA ostium diameter and LAA depth between TEE and CT.

Overview

Brief Summary

Accurate sizing of the left atrial appendage (LAA) is essential for selecting the appropriate device during percutaneous LAA occlusion procedures and for planning electrophysiology interventions.

Transesophageal echocardiography (TEE) is commonly used during procedures because of its excellent temporal resolution and ability to visualize the appendage. However, its semi-invasive nature and limited foreshortening can affect measurement accuracy.

Multidetector computed tomography (CT) offers high spatial resolution and the ability to perform true-orthogonal reformatting, which allows for precise assessment of complex LAA anatomy. CT measurements, however, can be influenced by factors such as the timing of the contrast bolus and cardiac phase (Sattar Y et al., 2022).

This prospective, blinded study compares TEE with contrast-enhanced CT for assessing LAA dimensions. The primary endpoint is the agreement between the two modalities in measuring the LAA ostium diameter and appendage depth. This is analyzed using Bland-Altman analysis, with CT serving as the spatial reference due to its high isotropic resolution (Soh BWT et al., 2024).

Secondary endpoints include comparing LAA morphological subtypes and location classification between the two imaging methods.

We will enroll adult patients who are already scheduled for routine TEE and a prescribed cardiac CT. Eligible participants will receive an additional contrast-enhanced cardiac CT at no cost, performed during the same clinical visit or within 48 hours to avoid anatomical changes.

Two independent readers, each focused on a specific imaging modality and blinded to each other’s results and clinical data, will measure the LAA ostium diameter and depth using predefined anatomical landmarks. All data will be securely stored for later statistical analysis, allowing a direct comparison of imaging results and an evaluation of TEE performance under blinded conditions.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients undergoing TEE who require Cardiac CT, as indicated medically.

Exclusion Criteria

  • Patients with cyanoic congenital heart disease Patients who have undergone LAA appendage closure Hemodynamically unstable patient Acute/chronic kidney disease Suspected esophageal varices Upper GI bleed International Normalized Ratio greater than 1.5 Past history of allergic or anaphylaxis to contrast Age less than 18 years Irregular rhythm where gating is not possible.
  • Non-consenting patients.

Outcomes

Primary Outcomes

Inter modality agreement mean bias and 95 percent limits of agreement on Bland Altman analysis for LAA ostium diameter and LAA depth between TEE and CT.

Time Frame: Baseline

Secondary Outcomes

  • Correlate anatomical types & location of left atrial appendage identified by TEE with Contrast Cardiac CT.(Baseline)

Investigators

Sponsor
nference Labs Private Limited
Sponsor Class
Other [Medical Device]
Responsible Party
Principal Investigator
Principal Investigator

Dr Anandamoyee Dhar

MAX Healthcare

Study Sites (1)

Loading locations...

Similar Trials